Related Experiment Videos
Leukocytoclastic angiitis induced by clindamycin
Cutis
|November 1, 1982
Summary
A patient developed leukocytoclastic vasculitis (LCV) after taking clindamycin. The LCV resolved upon drug discontinuation and reappeared upon re-administration, suggesting a drug-induced allergic reaction.
Area of Science:
- Dermatology
- Rheumatology
- Pharmacology
Background:
- Leukocytoclastic vasculitis (LCV) is a small-vessel vasculitis with various potential causes.
- Drug-induced vasculitis is an important differential diagnosis in patients presenting with LCV.
Observation:
- A 56-year-old male with diabetes experienced a skin eruption consistent with LCV.
- The patient had recently been treated with clindamycin for a diabetic foot ulcer infection.
Findings:
- The patient's LCV resolved after discontinuing clindamycin.
- The vasculitis recurred upon re-challenge with clindamycin and again resolved upon withdrawal.
- This strongly suggests clindamycin as the causative agent for the LCV.
Implications:
- Clindamycin can induce leukocytoclastic vasculitis as an idiosyncratic drug reaction.
- Clinicians should consider clindamycin and lincomycin allergy in the differential diagnosis of LCV, especially in patients using these antibiotics.
- Prompt recognition and drug withdrawal are crucial for managing drug-induced LCV.